Visual screening for malignant melanoma: a cost-effectiveness analysis
about
Survival is not the only valuable end point in melanoma screeningScreening and prevention measures for melanoma: is there a survival advantage?Skin surveillance intentions among family members of patients with melanomaAssessment of patient-reported outcomes in patients with melanoma.Strategies for early melanoma detection: Approaches to the patient with neviThe epidemiology, prevention, and detection of melanoma.Knowledge, perceptions, and practices of chiropractic interns in the early detection of atypical moles.Public health engagement: detection of suspicious skin lesions, screening and referral behaviour of UK based chiropractors.Identifying risk factors using a skin cancer screening programProposal for an annual skin examination by a general practitioner for patients at high risk for melanoma: a French cohort study.Melanoma screening: A plan for improving early detection.Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis.Adenovirus-mediated expression of mutated forkhead human transcription like-1 suppresses tumor growth in a mouse melanoma xenograft modelOverview of methods in economic analyses of behavioral interventions to promote oral healthA systematic review of advanced practice nurses' skin cancer assessment barriers, skin lesion recognition skills, and skin cancer training activities.Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.A Markov Decision Process Model for Cervical Cancer Screening Policies in Colombia.The role of spatially-derived access-to-care characteristics in melanoma prevention and control in Los Angeles county.Identifying people at higher risk of melanoma across the U.K.: a primary-care-based electronic survey.Anxiety, locus of control and sociodemographic factors associated with adherence to an annual clinical skin monitoring: a cross-sectional survey among 1000 high-risk French patients involved in a pilot-targeted screening programme for melanomaDevelopment of a targeted risk-group model for skin cancer screening based on more than 100,000 total skin examinations.Three cases of scalp melanomas discovered by hairdressers.Cost-effectiveness of a FISH assay for the diagnosis of melanoma in the USA.Estimating the cost of skin cancer detection by dermatology providers in a large healthcare system.Health-related quality of life in patients with melanoma expressed as utilities and disability weights.Knowledge, attitudes and skills in melanoma diagnosis among doctors: a cross sectional study from Sri Lanka.Cox-2 Inhibitors in the Prevention of MelanomaColour-based dermoscopy classification of cutaneous lesions: an alternative approach
P2860
Q26863767-3ADC39C0-A82C-4D12-BC50-6441A5B655E0Q28391892-01A99974-E6CE-4E14-8653-6506151669A6Q28395172-147A5512-C017-420B-8C5C-DBFE748616A0Q34371938-F3CE8F9E-6792-40EC-BEF4-0D864BB6EC4FQ34606851-2D819B36-7908-4B34-8546-C697FDCFD8B4Q34629383-1113ED6C-AD06-4D5D-B9D2-762A7309E615Q35032073-A565B771-93BA-4DB3-A774-B86A83CA5A91Q35041392-89EE80AB-5621-47E5-87EE-FC63AE0D3065Q35891961-85D8015D-E4B0-4C1F-A193-D528131616B3Q35906733-AFD7ABB5-2981-47C3-8CA7-92A0CF6FFD85Q35934413-26618831-4E98-4D69-A87B-136F73BCFA06Q36277934-F1419014-8684-4BFF-9BCC-FFB84145ECB9Q36312152-F96EC096-4EAE-4F46-BB35-C9E9A26E2F42Q36745358-727F2EA2-5691-47F9-9B21-5538B4054987Q37965225-CC3B1872-AFDC-4C1E-B3CA-28A7FE83EF84Q38652548-BA1BD1F2-5DE4-4962-AB7B-E944FA1BC50EQ38800654-E162B92B-9315-4DA4-B3C6-2973D90F69DAQ38846228-9A5C4429-7A03-4A74-B220-B27960D3F3DDQ39069265-7AB20BAD-AB13-4FC2-946A-E21048C90ED2Q42376811-C05CC82F-C292-4740-BCA1-F420A349407BQ42484750-C498ACC9-643D-477C-BBA6-470283CAC658Q42581807-0005342E-8028-4CB5-8381-4C05611036E3Q45661783-E79EA3A5-DD87-4131-9B03-33E7A1E60ED7Q47406698-1E481598-4DD8-4463-960C-D1CBCF32E55FQ48070452-061038D9-1DD9-4383-9FE8-5DA72BA4C907Q55410913-20764581-E66F-4EFD-B482-BF7699426109Q57243674-E147F274-2FE4-4E63-A4BB-88419A0B8E67Q57957661-4676A7F0-17BD-408B-9468-AB40ECD1782E
P2860
Visual screening for malignant melanoma: a cost-effectiveness analysis
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Visual screening for malignant melanoma: a cost-effectiveness analysis
@ast
Visual screening for malignant melanoma: a cost-effectiveness analysis
@en
type
label
Visual screening for malignant melanoma: a cost-effectiveness analysis
@ast
Visual screening for malignant melanoma: a cost-effectiveness analysis
@en
prefLabel
Visual screening for malignant melanoma: a cost-effectiveness analysis
@ast
Visual screening for malignant melanoma: a cost-effectiveness analysis
@en
P2093
P2860
P50
P1433
P1476
Visual screening for malignant melanoma: a cost-effectiveness analysis
@en
P2093
Alan Geller
Frederick C Beddingfield
Lindsey L Wolf
P2860
P356
10.1001/ARCHDERM.143.1.21
P577
2007-01-01T00:00:00Z